Clinical trials: Percutaneous Tumor Ablation
Lung Cancer
Microwave Ablation in Pulmonary Malignancies
Lung cancer remains to be an important global issue as it is the leading cause of cancer_ related mortality for both men and women worldwide .Since more than two thirds of cases are diagnosed at an advanced stage,the survival…
- Trial name
- NCT04081181
- Testing
- Microwave ablation
- Volunteers
- 19 people
- Sponsor
- Assiut University
Osteoid Osteoma
Zoledronic Acid Compared to Percutaneous Treatment in Osteoid Osteoma
Osteoid osteoma (OO) is a benign osteogenic tumor occurring in children and young adults, responsible for intense bone pain, which has a tendency to spontaneously heal with mineralization of the nidus, but extremely slowly.
- Trial name
- BISPHOO (NCT02739555)
- Testing
- Thermal destruction with radiofrequency or laser, Acide Zoledronique
- Where
- 16 sites in France
- Volunteers
- 15 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Breast Tumor, Microwave Ablation
Comparison of Microwave Ablation With Cryoablation for Breast Tumor
The investigators will perform this study to prospectively compare the clinical outcome after percutaneous microwave ablation(MWA) and cryoablation of benign and malignant breast lesion under ultrasound (US) guidance.
- Conditions
- Breast Tumor, Microwave Ablation, Cryoablation
- Trial name
- NCT03286413
- Testing
- microwave ablation
- Where
- China
- Volunteers
- 250 people
- Sponsor
- Chinese PLA General Hospital
Lung Cancer
Percutaneous Thermal Ablation in Lung Tumors
Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females.
- Trial name
- Radiofrequency (NCT06891183)
- Testing
- Percutaneous thermal ablation of lung tumors
- Where
- Egypt
- Volunteers
- 50 people
- Sponsor
- Assiut University
Renal Cell Carcinoma
Comparison Between Partial Nephrectomy and Ablation for Renal Tumor
The therapeutic effectiveness of ultrasound guided cooled-probe microwave ablation and laparoscopic partial nephrectomy on T1a renal cell carcinoma is compared to find a better approach for renal tumor.
- Trial name
- NCT03094949
- Testing
- Partial Nephrectomy, microwave ablation
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Chinese PLA General Hospital
Sarcoma
BORIS - aBlação pOR mIcro-ondaS [Microwave Ablation]
Patients with sarcoma and lung metastases have few therapeutic options, with poor response to systemic treatment. Many of them are not eligible to surgical treatments due to the high number and distribution of pulmonary lesions…
- Trial name
- BORIS (NCT04510714)
- Testing
- Image guided percutaneous microwave ablation
- Where
- Brazil
- Volunteers
- 60 people
- Sponsor
- Instituto do Cancer do Estado de São Paulo
Neoplasm of Breast
Ultrasound Guided Percutaneous Microwave Ablation for Breast Lesions
The investigators will perform this study to prospectively analyse the clinical outcome after percutaneous microwave ablation(MWA) of benign and malignant breast lesion under ultrasound (US) guidance.
- Trial name
- NCT02860104
- Testing
- microwave ablation
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Chinese PLA General Hospital
Unrecognized Condition
Air Dissection in Percutaneous Radiofrequency Ablation of T1a Renal Cell Carcinoma
The investigators aimed to evaluate the feasibility and safety of using ambient air to protect against thermal injury during RadioFrequency Ablation (RFA) for Renal Cell Carcinoma (RCC) based on data from cases at their institute.
- Trial name
- NCT03395379
- Testing
- RFA
- Volunteers
- 90 people
- Sponsor
- Centre Hospitalier Universitaire de Nice
Hepatocellular Carcinoma
RFA for Treatment of Intermediate Stage HCC
In Egypt, chronic hepatitis C virus (HCV) is the most prevalent cause of hepatoma. The study aims to evaluate the percutaneous radiofrequency ablation (RFA) efficacy as monotherapy in intermediate versus early-stage…
- Trial name
- NCT05281783
- Testing
- percutaneous radiofrequency ablation (RFA)
- Where
- Egypt
- Volunteers
- 120 people
- Sponsor
- Benha University
Soft Tissue Neoplasms
Radiofrequency Ablation of Painful Soft Tissue Neoplasms
Radiofrequency ablation is used to treat patients with many different conditions. It is used to treat heart arrhythmia and benign bone tumors, and to control bleeding during surgery.
- Trial name
- NCT00041886
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- National Institutes of Health Clinical Center (CC)
Heart Neoplasms
The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study
The safety and efficacy evaluation of echocardiography-guided percutaneous radiofrequency ablation (Liwen prcocedure) for cardiac tumors: a single-arm, prospective, single-center clinical study.
- Trial name
- NCT06830512
- Testing
- Echocardiography-guided percutaneous radiofrequency ablation for cardiac tumors
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Xijing Hospital
Carcinoma, Hepatocellular
Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma
Ethanol injection has been for many years the standard approach as percutaneous treatment of non-surgical early hepatocellular carcinoma in cirrhotic patients.
- Trial name
- NCT00355212
- Testing
- percutaneous ablation of hepatocellular carcinoma
- Where
- Italy
- Volunteers
- 240 people
- Sponsor
- Azienda Ospedaliera San Giovanni Battista
Neoplasms, Carcinoma
Clinical Trials of CT-guided Percutaneous Irreversible Electroporation（IRE）in the Treatment of Patients With Locally Advanced Tumors
Irreversible electroporation (IRE) is an emerging nonthermal focal ablation technique that uses a series of short but intense electric pulses delivered by NanoKnife generator through paired electrodes into a targeted region of…
- Trial name
- NCT02567734
- Testing
- CT-guided percutaneous irreversible electroporation
- Where
- China
- Volunteers
- 20 people
- Sponsor
- Yueyong Xiao
Liver Neoplasms
Percutaneous Microwave Ablation Under Ultrasound Guidance for Liver Cancer: a Multicenter Analysis
Ultrasound-guided percutaneous MWA of liver cancer is a relatively new technique with favorable long-term outcomes.Butthe results are mainly from single center reports.A larger scale data need to be analyzed to evaluate the…
- Trial name
- NCT03045952
- Testing
- microwave ablation device
- Where
- China
- Volunteers
- 1,908 people
- Sponsor
- Chinese PLA General Hospital
Radiofrequency Ablation, Ultrasonography
Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation
Contrast-enhanced ultrasonography (CEUS)-CT/MRI fusion imaging substantially improved the visibility of small tumors that were inconspicuous on both US and US-CT/MRI fusion imaging, contributing to successful percutaneous…
- Conditions
- Radiofrequency Ablation, Ultrasonography, Liver Tumors
- Trial name
- NCT05445973
- Testing
- Percutaneous Radiofrequency Ablation
- Where
- South Korea
- Volunteers
- 248 people
- Sponsor
- Seoul National University Hospital
Hepatocellular Carcinoma
Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis
The purpose of this study is to assess the efficacy of Radiofrequency ablation (RFA) and percutaneous acetic acid ablation (PAI) in the management of small hepatocellular carcinoma (HCC) in patients of cirrhosis of liver.
- Trial name
- NCT01438437
- Testing
- PAI, RFA
- Where
- India
- Volunteers
- 54 people
- Sponsor
- All India Institute of Medical Sciences